Internal Medicine, Gastroenterology · Scottsdale, AZ
NPI
1891778643
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13400 E Shea Blvd
Scottsdale, AZ, 85259
Phone (480) 301-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,020 services
Medicare patients, 2024
527
Average age 73
Drug cost, 2024
$209K
783 prescriptions
Company payments, 2025
$645
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lucinda A Harris was code 99214 (office e&m - established), 149 times for 126 patients. In total Lucinda A Harris billed 1,020 services in 43 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 149 | 126 | $91.39 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 107 | 53 | $58.78 | $6,290 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 102 | 99 | $4.08 | $416 |
| 45380 Lower GI Endoscopy - Other | Facility | 93 | 93 | $93.60 | $8,705 |
| 43239 Upper GI Endoscopy | Facility | 84 | 82 | $75.54 | $6,345 |
| 45385 Colonoscopy - Lesion Removal | Facility | 64 | 64 | $193.63 | $12K |
| 99211 Office E&M - Established | Office | 62 | 61 | $16.75 | $1,039 |
| 99213 Office E&M - Established | Office | 62 | 56 | $66.27 | $4,109 |
| 99222 Hospital E&M - Initial | Facility | 42 | 42 | $82.45 | $3,463 |
| 99215 Office E&M - Established | Office | 35 | 35 | $118.96 | $4,164 |
| 99205 Office E&M - New | Office | 29 | 29 | $161.82 | $4,693 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 21 | 21 | $174.55 | $3,665 |
| 99204 Office E&M - New | Office | 18 | 18 | $129.22 | $2,326 |
| 43235 Upper GI Endoscopy | Facility | 15 | 15 | $81.00 | $1,215 |
| 43248 Upper GI Endoscopy | Facility | 14 | 13 | $106.45 | $1,490 |
By year: 2022 $86K for 1,071 services; 2023 $85K for 987 services; 2024 $88K for 1,020 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lucinda A Harris prescribed most often to Medicare patients was Pantoprazole Sodium, with 94 prescriptions and refills. In total Lucinda A Harris wrote 783 Medicare prescriptions that cost $209K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 94 | 186 | 24 | $3,364 |
| Motegrity Prucalopride Succinate | 49 | 66 | Under 11 | $42K |
| Omeprazole Generic | 47 | 126 | 15 | $589 |
| Linzess Linaclotide | 36 | 60 | Under 11 | $32K |
| Doxycycline Monohydrate Generic | 23 | 45 | Under 11 | $1,312 |
| Pyridostigmine Bromide Generic | 23 | 25 | Under 11 | $1,954 |
| Metoclopramide Hcl Generic | 21 | 33 | Under 11 | $184 |
| Gabapentin Generic | 21 | 23 | Under 11 | $268 |
| Nortriptyline Hcl Generic | 21 | 34 | Under 11 | $257 |
| Ondansetron Hcl Generic | 19 | 25 | Under 11 | $250 |
| Budesonide Dr Budesonide | 18 | 27 | Under 11 | $761 |
| Lansoprazole Generic | 17 | 27 | Under 11 | $855 |
| Famotidine Generic | 17 | 45 | Under 11 | $265 |
| Erythromycin Erythromycin Base | 16 | 16 | Under 11 | $1,213 |
| Famotidine Famotidine/Pf | 15 | 15 | Under 11 | $461 |
Brand drugs: 172 claims; generic drugs: 611 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lucinda A Harris $645 ($645 in general payments such as food, travel and fees) from 4 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $284.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.